Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

Jennifer G. Robinson; Bettina S. Nedergaard; William J. Rogers; Jonathan Fialkow; Joel M. Neutel; David Ramstad; Ransi Somaratne; Jason C. Legg; Patric Nelson; Robert C. Scott; Scott M. Wasserman; Robert Weiss

doi:10.1001/jama.2014.4030

Abstract

clinicaltrials.gov Identifier: NCT01763866.

Keywords

EvolocumabMedicineRosuvastatinAtorvastatinEzetimibeTolerabilityStatinPlaceboPCSK9Internal medicineAlirocumabGastroenterologySimvastatinRandomized controlled trialDyslipidemiaRosuvastatin CalciumUrologyCholesterolApolipoprotein BLipoproteinAdverse effectLDL receptor

Affiliated Institutions

Related Publications

Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR**STELLAR = Statin Therapies for Elevated Lipid Levels compared Across doses to Rosuvastatin. Trial)

Peter H. Jones , Michael H. Davidson , Evan A. Stein +5 more

The primary objective of this 6-week, parallel-group, open-label, randomized, multicenter trial was to compare rosuvastatin with atorvastatin, pravastatin, and simvastatin acros...

2003 The American Journal of Cardiology 1382 citations

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction<SUBTITLE>The IDEAL Study: A Randomized Controlled Trial</SUBTITLE>

Terje R. Pedersen

In this study of patients with previous MI, intensive lowering of LDL-C did not result in a significant reduction in the primary outcome of major coronary events, but did reduce...

2005 JAMA 1539 citations

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

M R Law

Statins can lower LDL cholesterol concentration by an average of 1.8 mmol/l which reduces the risk of IHD events by about 60% and stroke by 17%.

2003 BMJ 1717 citations

Comparison of Once-Daily, niacin Extended-Release/lovastatin with standard doses of atorvastatin and simvastatin (the advicor versus other Cholesterol-Modulating agents trial evaluation [ADVOCATE])

Harold Bays , Carlos A. Dujovne , Mark E. McGovern +4 more

This study compared the relative efficacy of a once-daily niacin extended-release (ER)/lovastatin fixed-dose combination with standard doses of atorvastatin or simvastatin, with...

2003 The American Journal of Cardiology 153 citations

Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT

Erin A. Bohula , Robert P. Giugliano , Christopher P. Cannon +6 more

Background— Statins lower low-density lipoprotein cholesterol (LDL-C) and high-sensitivity C-reactive protein (hs-CRP); addition of ezetimibe to statins further reduces LDL-C an...

2015 Circulation 327 citations

Publication Info

Year: 2014
Type: article
Volume: 311
Issue: 18
Pages: 1870-1870
Citations: 488
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

488

OpenAlex

Cite This

APA Style

                            
                                
                                    Jennifer G. Robinson, 
                                
                                    Bettina S. Nedergaard, 
                                
                                    William J. Rogers
                                
                                et al.
                            
                            (2014). 
                            Effect of Evolocumab or Ezetimibe Added to Moderate- or High-Intensity Statin Therapy on LDL-C Lowering in Patients With Hypercholesterolemia. 
                            JAMA
                            , 311
                            (18)
                            , 1870-1870.
                            https://doi.org/10.1001/jama.2014.4030
                        

Identifiers

DOI: 10.1001/jama.2014.4030